How to manage menopausal symptoms

Written by: Professor Gordana Prelevic
Published:
Edited by: Lisa Heffernan

For women with menopausal symptoms, making a personal, informed decision about beginning HRT, otherwise known as hormone replacement therapy, can be challenging and scary. The duration and initiation of treatment requires careful monitoring. Hormone replacement therapy is, in other words, a form of hormone therapy used to treat symptoms associated with the menopause. We asked Professor Gordana Prelevic, a consultant endocrinologist, to tell us about HRT, the associated risks and alternative therapies.

HRT needs to be individualised

Postmenopausal therapy needs to be individualised because the risks associated with HRT depend on the health of the individual. Preparation for treatment, who should be treated and for how long all depend on factors such as a woman’s age, medical history, family medical history, reasons for treatment and the potential risks and side effects that each woman might face.

 

What is the gold standard HRT treatment for menopausal symptoms?

Oestrogen therapy is considered the gold standard treatment, effective in 90% of women with hot flushes. Low doses of oestrogen are sufficient to control even the severest of symptoms and are also effective in maintaining bone mass.

 

Are there risks with hormone replacement therapy?

Any potential risks with hormone replacement therapy are related to dosage, age of a woman and the route of administration of oestrogen (oral or transdermal) . Therefore, the lowest effective oestrogen dose will be used for the shortest amount of time possible. When undergoing HRT, women should be examined annually with the aim to decrease the dose of HRT or discontinue HRT altogether.

Short-term HRT is appropriate for perimenopausal and postmenopausal women, who have moderate to severe vasomotor symptoms (hot flushes and sweats) associated with a lack of oestrogen. Transdermal administration, using gel or a patch is safer, at least in terms of the risk of venous thrombosis.

The risk of breast cancer appears to increase with long-term use of HRT (after four to five years). This risk is significantly greater in women who are on combined (oestrogen and progesterone treatment) than in women who had a hysterectomy and therefore need oestrogen alone.

The risk of a stroke increases in women over the age of 60. HRT with this age group should be discouraged, unless the patient has very severe menopausal symptoms.

Read more: Risks of HRT

Are there alternatives to hormone replacement therapy?

For women who fear the potential risks of HRT, alternatives can be considered. However, there is not sufficient evidence at present to support the clinical use of alternative products and whether “natural” necessarily implies safer and effective treatment. Standardisation of dosage, together with safety and correct and clear labelling is essential when looking into complimentary therapy products.

Lifestyle changes can be just as important as using medication and alternative therapy to control symptoms of the menopause.

  • Foods that trigger hot flushes like alcohol, spicy food and hot drinks should be avoided.
  • Regular exercise can reduce hot flushes and has other benefits in improving quality of life. It can help women normalise weight and also prevent postmenopausal bone loss.
  • Both acupuncture and the use of trained relaxation techniques on a daily basis have shown significant benefits in controlling hot flushes.

 

For more information about treating symptoms of the menopause with HRT, make an appointment with a consultant endocrinologist like Professor Gordana Prelevic.

By Professor Gordana Prelevic
Endocrinology, diabetes & metabolism

Professor Gordana Prelevic is one of London's leading consultant endocrinologists with over 40 years of experience. Her main area of expertise is reproductive endocrinology with special interests in polycystic ovary syndrome (PCOS), menopause, and osteoporosis

Professor Prelevic earned a Doctor of Medicine (MD) in 1971, a Master of Science (MSc) in endocrinology in 1978, and a Doctor of Science (DSc) in reproductive endocrinology in 1985, all from the University of Belgrade. She was a professor of medicine at the Belgrade University School of Medicine and head of the division of endocrinology at Zvezdara University Medical Centre, Belgrade until 1993, when she moved to the UK. In 1995 she was awarded a Fellowship of the Royal College of Physicians.  

Professor Gordana Prelevic practises at the Golders Green Outpatients & Diagnostic Centre and the Platinum Medical Centre. In her clinic, she sees patients with a wide range of hormonal disorders and a large proportion of her work focuses on the management of perimenopausal and postmenopausal women. Additionally, she sees patients with unwanted hair growth (hirsutism), hyperprolactinaemia, infertility, and thyroid disorders. 

She has published extensively, particularly on various aspects of PCOS in peer-reviewed journals and has contributed to numerous book chapters. Her work has been presented at several scientific meetings internationally. From 1996 to 2005, she held a position as a senior lecturer in reproductive endocrinology at Royal Free & University College London Medical School. She also works as an expert witness in endocrinology and forms an integral part of various reputable professional bodies. 

View Profile

Overall assessment of their patients


  • Related procedures
  • Alopecia
    Hyperhidrosis
    Eating disorders
    Erectile dysfunction
    Menopause
    Polycystic ovary syndrome (PCOS)
    Hypertension (high blood pressure)
    Infertility
    Disorder of sexual desire of man
    Clinical nutrition
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.